Erratum to: Tward, J; Lenz, L; Flake II, DD; Rajamani, S; Yonover, P; Olsson, C; Kapoor, DA; Mantz, C; Liauw, SL; Antic, T; Fabrizio, M; Salzstein, D; Shore, N; Albertson, D; Henderson, J; Lee, SP; Gay, HA; Michalski, J; Hung, A; Raben, D; Garraway, I; Lewis, MS; Nguyen, PL; Marshall, DT; Brawer, MK; Stone, S; Cohen, T. The clinical cell-cycle risk (CCR) score is associated with metastasis after radiation therapy and provides guidance on when to forgo combined androgen deprivation therapy with dose-escalated radiation. Int J Radiat Oncol Biol Phys 2022;113:66-76. doi.org/10.1016/j.ijrobp.2021.09.034
Int J Radiat Oncol Biol Phys
.
2023 Feb 1;115(2):543.
doi: 10.1016/j.ijrobp.2022.09.070.
PMID:
36621237
DOI:
10.1016/j.ijrobp.2022.09.070
No abstract available
Publication types
Published Erratum